Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,856 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $483.82 | 32 | $0 (2024) |
| ABBVIE INC. | $474.57 | 36 | $0 (2024) |
| PFIZER INC. | $237.47 | 23 | $0 (2024) |
| Lilly USA, LLC | $221.07 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $207.11 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $184.21 | 11 | $0 (2024) |
| Exact Sciences Corporation | $153.30 | 6 | $0 (2024) |
| Amgen Inc. | $133.09 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $102.21 | 7 | $0 (2024) |
| Corcept Therapeutics | $95.54 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,079 | 65 | Novo Nordisk Inc ($221.87) |
| 2023 | $782.97 | 50 | ABBVIE INC. ($172.34) |
| 2022 | $620.42 | 50 | PFIZER INC. ($145.45) |
| 2021 | $374.22 | 26 | Novo Nordisk Inc ($82.05) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Endocrinology | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $33.42 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Endocrinology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Oncology | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.11 | General |
| 07/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Obesity | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 372 | 444 | $128,860 | $30,500 |
| 2022 | 8 | 335 | 406 | $109,388 | $26,569 |
| 2021 | 9 | 313 | 392 | $100,662 | $24,444 |
| 2020 | 4 | 193 | 223 | $63,567 | $11,306 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 216 | $78,408 | $16,586 | 21.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $14,292 | $4,351 | 30.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 51 | 51 | $14,280 | $3,617 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 45 | $11,115 | $2,291 | 20.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $6,380 | $1,693 | 26.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,264 | $1,000 | 79.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $595.00 | $577.49 | 97.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 42 | $2,478 | $358.23 | 14.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $48.00 | $26.40 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 144 | $52,272 | $11,888 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 89 | $21,983 | $4,719 | 21.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 40 | 41 | $11,480 | $2,953 | 25.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $9,131 | $2,847 | 31.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 24 | 48 | $11,088 | $2,454 | 22.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $962.00 | $891.02 | 92.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $525.00 | $505.35 | 96.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 32 | 33 | $1,947 | $311.90 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 111 | $40,293 | $8,763 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 118 | $29,146 | $6,540 | 22.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 27 | 27 | $10,719 | $3,422 | 31.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 30 | 30 | $8,400 | $2,339 | 27.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 15 | 39 | $9,009 | $2,119 | 23.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $876.00 | $774.56 | 88.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $455.00 | $252.93 | 55.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 28 | 28 | $1,652 | $184.16 | 11.1% |
About Nerlande Joasil, APN
Nerlande Joasil, APN is a Family healthcare provider based in Cedar Knolls, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1952673535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nerlande Joasil, APN has received a total of $2,856 in payments from pharmaceutical and medical device companies, with $1,079 received in 2024. These payments were reported across 191 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,856).
As a Medicare-enrolled provider, Joasil has provided services to 1,213 Medicare beneficiaries, totaling 1,465 services with total Medicare billing of $92,819. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Cedar Knolls, NJ
- Active Since 01/30/2012
- Last Updated 01/30/2012
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952673535
Products in Payments
- VRAYLAR (Drug) $255.56
- Wegovy (Drug) $235.30
- MOUNJARO (Drug) $213.16
- XIFAXAN (Drug) $184.21
- Cologuard Collection Kit (Device) $153.30
- UBRELVY (Drug) $122.04
- TRELEGY ELLIPTA (Drug) $109.50
- Korlym (Drug) $95.54
- PREVNAR 13 (Biological) $91.30
- QULIPTA (Drug) $84.92
- Vascepa (Drug) $83.22
- EVENITY (Biological) $77.12
- Ozempic (Drug) $69.51
- ELIQUIS (Drug) $67.02
- Odactra (Drug) $65.22
- PREVNAR 20 (Biological) $62.15
- SHINGRIX (Biological) $62.13
- BREZTRI (Drug) $58.87
- APLENZIN (Drug) $55.21
- NURTEC ODT (Drug) $51.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cedar Knolls
Mrs. Natia Rufolo, Apn, APN
Family — Payments: $3,079
Jillian Nati, Fnp, FNP
Family — Payments: $1,840
Alexa Dendulk, Fnp-C, Apn, FNP-C, APN
Family — Payments: $1,278
Molly Lawrence
Family — Payments: $921.57
Nathalie Hughes
Family — Payments: $906.82
Kaltrina Osmani
Family — Payments: $167.05